Financials
- Market Capitalization 78.6 M
- Employee 306
- Founded 1985
- CEO N/A
- Website www.championsoncology.com
- Headquarter Delaware, United States
- FIGI BBG000BYGPJ9
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4088 | ENTX Entera Bio Ltd. - Ordinary Shares | 1.62 USD | -1.22% | -0.61% | +33.88% | -18.59% | 79.75 M USD | ||
| 4096 | RNTX Rein Therapeutics, Inc. - Common Stock | 0.92 USD | +1.10% | -7.07% | -8.00% | -16.39% | 78.70 M USD | ||
| 4117 | PMVP PMV Pharmaceuticals, Inc. - Common Stock | 1.42 USD | +10.94% | +13.60% | +32.71% | +6.77% | 75.73 M USD | ||
| 4140 | ATRA Atara Biotherapeutics, Inc. - Common Stock | 8.04 USD | -7.27% | -19.92% | -18.95% | -45.49% | 72.44 M USD |
Frequently asked questions about Champions Oncology, Inc. - Common Stock
What is the Champions Oncology, Inc. - Common Stock stock price today?
The current price of Champions Oncology, Inc. - Common Stock (CSBR) is 5.66. Over the past 24 hours, the stock has changed by -2.58%. Follow the CSBR chart for real-time price dynamics.
What is the stock ticker of Champions Oncology, Inc. - Common Stock?
Champions Oncology, Inc. - Common Stock trades under the ticker CSBR. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Champions Oncology, Inc. - Common Stock stock going up?
CSBR has changed by -5.98% over the last week, -10.73% over the last month, and -27.53% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Champions Oncology, Inc. - Common Stock net income for the last quarter?
Champions Oncology, Inc. - Common Stock reported net income of -279 K for the last quarter. The previous quarter showed 268 K, which means net income changed by -204.10%.
How many employees does Champions Oncology, Inc. - Common Stock have?
As of the latest available data, Champions Oncology, Inc. - Common Stock has 306 employees. Workforce size can provide additional context about the company's scale and operations.
What is Champions Oncology, Inc. - Common Stock EBITDA?
Champions Oncology, Inc. - Common Stock EBITDA is -14.35 M, and its EBITDA margin is -87.11%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Champions Oncology, Inc. - Common Stock stock?
You can buy Champions Oncology, Inc. - Common Stock (CSBR) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Champions Oncology, Inc. - Common Stock stock?
Investing in Champions Oncology, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CSBR chart and related analysis on metatrader.com as part of your research.